Lumosa Therapeutics Co., Ltd. (6535.TWO)
TWD 160.0
(-9.86%)
TWD 160.0
(-9.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 41.48 Million TWD | 184.88% |
| 2022 | 14.56 Million TWD | 47.24% |
| 2021 | 9.88 Million TWD | -24.84% |
| 2020 | 13.15 Million TWD | -87.45% |
| 2019 | 104.82 Million TWD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.37 Million TWD | -90.61% |
| 2024 Q2 | 5 Million TWD | 264.97% |
| 2023 Q2 | 11.34 Million TWD | 694.26% |
| 2023 Q4 | 14.68 Million TWD | 4.71% |
| 2023 FY | 41.48 Million TWD | 184.88% |
| 2023 Q1 | 1.42 Million TWD | -73.79% |
| 2023 Q3 | 14.02 Million TWD | 23.66% |
| 2022 Q3 | -1.69 Million TWD | 0.0% |
| 2022 FY | 14.56 Million TWD | 47.24% |
| 2022 Q4 | 5.44 Million TWD | 421.47% |
| 2021 FY | 9.88 Million TWD | -24.84% |
| 2020 FY | 13.15 Million TWD | -87.45% |
| 2019 FY | 104.82 Million TWD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -12508.207% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.54 Million TWD | 89.695% |
| Level Biotechnology Inc. | 219.54 Million TWD | 81.106% |
| Sagittarius Life Science Corp | 71.47 Million TWD | 41.966% |
| NeoCore Technology Co., Ltd. | -9.08 Million TWD | 556.588% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 81.583% |
| GlycoNex Incorporation | 995 Thousand TWD | -4068.945% |
| VBI | 16.42 Million TWD | -152.579% |
| GeneReach Biotechnology Corp. | 27.58 Million TWD | -50.381% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 198.45 Million TWD | 79.098% |
| SynCore Biotechnology Co.,Ltd | 521 Thousand TWD | -7861.804% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 65.407% |
| Visgeneer Inc. | 67.48 Million TWD | 38.53% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 111.056% |
| Sunmax Biotechnology Co., Ltd. | 1.4 Billion TWD | 97.047% |
| G&E Herbal Biotechnology Co., Ltd. | 144.58 Million TWD | 71.311% |
| Neith Corporation | 18.01 Million TWD | -130.207% |
| Medigen Vaccine Biologics Corporation | 230.22 Million TWD | 81.982% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -82.398% |
| Enimmune corporation | -23.37 Million TWD | 277.474% |
| TaiRx, Inc. | 2.43 Million TWD | -1600.738% |
| CHO Pharma, Inc. | -28.27 Million TWD | 246.685% |
| EirGenix Inc. | 236.74 Million TWD | 82.478% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 60.249% |
| Sunny Pharmtech Inc. | 285.52 Million TWD | 85.472% |
| Lin BioScience, Inc. | -17.92 Million TWD | 331.388% |
| BioGend Therapeutics Co., Ltd. | 89.61 Million TWD | 53.714% |
| Feng Chi Biotech Corp. | 80.72 Million TWD | 48.612% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -3730.194% |
| Lukas Biomedical Inc. | 133.89 Million TWD | 69.019% |
| RBC Bioscience Corporation | 72.89 Million TWD | 43.095% |
| BiOptic Inc. | 152.74 Million TWD | 72.843% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -45990.0% |
| Shine-On BioMedical Co.,Ltd. | 6.66 Million TWD | -522.184% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1486.272% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 93.558% |
| Advagene Biopharma Co., Ltd. | -12 Million TWD | 445.617% |
| NaviFUS Corp. | 11.82 Million TWD | -250.731% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 96.77 Million TWD | 57.136% |
| Sinew Pharma Inc. | -28.98 Million TWD | 243.112% |
| Andros Pharmaceuticals Co.,Ltd | 313 Thousand TWD | -13152.716% |
| Greenyn Biotechnology Co., Ltd | 392.45 Million TWD | 89.43% |
| AP Biosciences Inc | 32.25 Million TWD | -28.611% |
| Medigen Biotechnology Corp. | 617.32 Million TWD | 93.281% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -686.519% |
| Pharmosa Biopharm Inc. | 314.5 Million TWD | 86.81% |
| Intech Biopharm Corporation | -163.99 Million TWD | 125.294% |
| Oneness Biotech Co., Ltd. | 32.56 Million TWD | -27.391% |
| Eusol Biotech Co.,Ltd. | -4.02 Million TWD | 1129.561% |
| TWi Biotechnology, Inc. | -9.73 Million TWD | 525.927% |
| Ever Supreme Bio Technology Co., Ltd | 484.75 Million TWD | 91.443% |
| TCI GENE Inc. | 174.61 Million TWD | 76.245% |
| MegaPro Biomedical Co., Ltd | -16.6 Million TWD | 349.87% |
| Senhwa Biosciences, Inc. | -10.17 Million TWD | 507.756% |
| Taiwan Bio Therapeutics Co., Ltd | 76.35 Million TWD | 45.676% |
| NatureWise Biotech & Medicals Corporation | 76.96 Million TWD | 46.103% |
| PharmaEngine, Inc. | 718.97 Million TWD | 94.231% |
| Savior Lifetec Corporation | 220.94 Million TWD | 81.226% |
| TaiGen Biopharmaceuticals Holdings Limited | 111.68 Million TWD | 62.859% |
| OBI Pharma, Inc. | -73.49 Million TWD | 156.439% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 70.13% |
| Acepodia, Inc. | 16.59 Million TWD | -149.991% |
| Caliway Biopharmaceuticals Co., Ltd. | 27.46 Million TWD | -51.01% |